载脂蛋白AI 来源于人血浆

np001139-100μg

100μg

生物活性

≥95%(SDS-PAGE)

高密度脂蛋白（HDL）中 75% 的载脂蛋白 A（Apo A）为载脂蛋白 AI（Apo AI）。载脂蛋白 AI（Apo AI）的水平与冠心病风险呈负相关。研究认为，载脂蛋白 AI（Apo AI）还可激活卵磷脂胆固醇酰基转移酶（LCAT，全称为 lecithin cholesterol acyl transferase）。正常血浆中载脂蛋白 AI（Apo AI）的水平范围为每 100 毫升 90 至 130 毫克。 由新鲜、未冷冻的血浆制备，经FDA批准的试验显示，乙型肝炎表面抗原（HBsAg）、抗丙型肝炎病毒（抗 - HCV）、抗乙型肝炎核心抗体（抗 - HBc）均为阴性，且抗人类免疫缺陷病毒 1 型和 2 型（抗 - HIV 1 & 2）也为阴性。 阿拉丁产品是实验室试剂，不得用于人类或用于任何药物目的。仅供研究使用。 75% of Apo A in HDL is Apo AI. Levels of Apo AI are inversely related to the risk of coronary heart disease. Apo AI is also thought to activate LCAT (lecithin cholesterol acyl tranferase). In normal plasma, Apo AI levels range from 90-130 mg per 100 ml. Prepared from fresh, non-frozen plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. Aladdin products are laboratory reagents and are not to be administered to humans or used for any drug purpose. For research use only.

Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility. Post-translational: Glycosylated. Palmitoylated. Phosphorylation sites are present in the extracellular medium.

天然

28 kDa

人(Human)